Erectile dysfunction & retrograde ejaculation due to BPH has COVID-19 protected treatment
Erectile dysfunction due to enlarged prostate or benign prostatic hyperplasia (BPH) often is a disgusting and annoying symptom for me over 50. Unfortunately, treatment options for men with BPH with standard drugs and surgeries can worsen sexual dysfunction adding retrograde ejaculation and loss of libido.
Today. it is also important to suggest a treatment for enlarged prostate that can protect men from getting COVID-19, so everyone can use the therapy without worrying to get this severe virus. The only therapy that has been working very well for men with BPH during the last decade without side effects is Dr Allen’s Device. Furthermore, Dr Allen’s Device is used at home, without visits clinics and hospitals therefore minimizing risk of getting COVID-19 from anyone.
Conventional treatments of BPH can cause new sexual problems
Many researchers found links between BPH drugs and surgeries and development of sexual dysfunction: erectile dysfunction, retrograde ejaculation and loss of libido. In the recent article: ‘Benign prostatic hyperplasia surgery and patient’s information: What do patients understand and remember?’ states that information given before a BPH surgery about complications is poor. This research concluded that a written information sheet is important for a good relationship between doctor and patient and judicial peace.
BPH drugs alpha-blockers (Flomax – tamsulosin, terazosin, etc.) can cause for retrograde ejaculation, sexual dysfunction, headache, tiredness, dizziness, problems with the bladder and even dementia. Moreover, alpha-blockers become ineffective in a couple of years.
BPH hormonal drugs: 5-alpha reductase inhibitors: finasteride and dutasteride cause more serious irreversible side effects: impotence, depression, testicle pain, cancer and even diabetes. However, due to severe side effects from 5-alpha reductase inhibitors, urologists reduce the dose and prescribe it as combination with alpha-blockers. However, a such combination of 2 drugs may worsen negative events.
After minimally invasive surgery men with BPH have unpleasant complications. As a result of them, approximately 25% of patients suffer from depression. A new article, ‘Retrograde ejaculation-a commonly unspoken aspect of prostatectomy for BPH, 2020, underlines that it is important for practicing family physicians and urologists to present retrograde ejaculation as a serious adverse effect and not to trivialize it.
To get BPH drugs or surgeries me must contact doctors by visiting clinics and hospital. As COVID-19 – coronavirus spreads from person to person, visiting hospitals or clinics is an undesirable hazard for aging men with BPH and for medical personal.
Dr Allen’s Device treats BPH at home, effectively and safe
Thermobalancing therapy with Dr Allen’s Device was patented by the USPTO. Fine Treatment https://finetreatment.com/ is a healthcare company, a manufacturer and distributor of wearable therapeutic Dr Allen’s Devices. The device is easy to use, it consists of a wearable belt that attaches a special natural thermoelement to the coccyx.
The clinical controlled study on Thermobalancing therapy was conducted in 124 men with BPH and confirmed the effectiveness and safety of Dr Allen’s device. Most unpleasant symptoms disappear within a few days or weeks, gradually improving symptoms of sexual dysfunction, improving potency and libido. Many scientific articles were published, https://finetreatment.com/thermobalancing-therapy-medical-scientific-data/.
The use of Dr Allen’s device reduces enlargement of the prostate naturally. Therefore, this therapy helps aging men with BPH avoid visits clinics and hospitals minimizing risks of getting coronavirus – COVID-19.
Dr Allen’s Device is registered with Medicines and Healthcare products Regulatory Agency in 2010, as a class 1 medical device. Therefore, it does not require the involvement of any medical body. So, every man with BPH can use as self-management tool without worrying, since the device is safe.